1 |
LU Y, WANG X Y, GU Q, et al. Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets[J]. Cell Death Discov, 2022, 8: 337.
|
2 |
GILLENTINE M A, WANG T Y, HOEKZEMA K, et al. Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders[J]. Genome Med, 2021, 13(1): 63.
|
3 |
VAN EEKELEN C A, VAN VENROOIJ W J. hnRNA and its attachment to a nuclear protein matrix[J]. J Cell Biol, 1981, 88(3): 554-563.
|
4 |
FENG S L, LI J M, WEN H, et al. hnRNPH1 recruits PTBP2 and SRSF3 to modulate alternative splicing in germ cells[J]. Nat Commun, 2022, 13: 3588.
|
5 |
BROWNMILLER T, CAPLEN N J. The HNRNPF/H RNA binding proteins and disease[J]. Wiley Interdiscip Rev RNA, 2023, 14(5): e1788.
|
6 |
HAN S P, TANG Y H, SMITH R. Functional diversity of the hnRNPs: past, present and perspectives[J]. Biochem J, 2010, 430(3): 379-392.
|
7 |
LUNDE B M, MOORE C, VARANI G. RNA-binding proteins: modular design for efficient function[J]. Nat Rev Mol Cell Biol, 2007, 8: 479-490.
|
8 |
ALKAN S A, MARTINCIC K, MILCAREK C. The hnRNPs F and H2 bind to similar sequences to influence gene expression[J]. Biochem J, 2006, 393(pt 1): 361-371.
|
9 |
VO T, BROWNMILLER T, HALL K, et al. HNRNPH1 destabilizes the G-quadruplex structures formed by G-rich RNA sequences that regulate the alternative splicing of an oncogenic fusion transcript[J]. Nucleic Acids Res, 2022, 50(11): 6474-6496.
|
10 |
VAN DUSEN C M, YEE L, MCNALLY L M, et al. A glycine-rich domain of hnRNP H/F promotes nucleocytoplasmic shuttling and nuclear import through an interaction with transportin 1[J]. Mol Cell Biol, 2010, 30(10): 2552-2562.
|
11 |
COLES J L, HALLEGGER M, SMITH C W. A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F[J]. RNA, 2009, 15(1): 33-43.
|
12 |
XU J, LU Z, XU M, et al. A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions[J]. J Neurosci, 2014, 34(33): 11048-11066.
|
13 |
LAFORCE G R, PHILIPPIDOU P, SCHAFFER A E. mRNA isoform balance in neuronal development and disease[J]. Wiley Interdiscip Rev RNA, 2023, 14(3): e1762.
|
14 |
GRAMMATIKAKIS I, ZHANG P, PANDA A C, et al. Alternative splicing of neuronal differentiation factor TRF2 regulated by HNRNPH1/H2[J]. Cell Rep, 2016, 15(5): 926-934.
|
15 |
ZHANG P, CASADAY-POTTS R, PRECHT P, et al. Nontelomeric splice variant of telomere repeat-binding factor 2 maintains neuronal traits by sequestering repressor element 1-silencing transcription factor[J]. Proc Natl Acad Sci USA, 2011, 108(39): 16434-16439.
|
16 |
FENG S, WEN H, LIU K, et al. hnRNPH1 establishes Sertoli-germ cell crosstalk through cooperation with PTBP1 and AR, and is essential for male fertility in mice[J]. Development, 2023, 150(3): dev201040.
|
17 |
马冉冉. 长链非编码RNA AK126420通过其结合蛋白HNRNPH1促进胃癌转移的作用机制研究[D]. 济南: 山东大学, 2019.
|
|
MA R R. The mechanism of lncRNA AK126420 promoting gastric cancer metastasis through its binding protein HNRNPH1[D]. Jinan: Shandong University, 2019.
|
18 |
XU H, DONG X, CHEN Y, et al. Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma[J]. Clin Chem Lab Med, 2018, 56(3): 479-484.
|
19 |
LUDVIGSEN M, THORLACIUS-USSING L, VORUM H, et al. Proteomic characterization of colorectal cancer tissue from patients identifies novel putative protein biomarkers[J]. Curr Issues Mol Biol, 2021, 43(2): 1043-1056.
|
20 |
YANG Y, JIA D, KIM H, et al. Dysregulation of miR-212 promotes castration resistance through hnRNPH1-mediated regulation of AR and AR-V7: implications for racial disparity of prostate cancer[J]. Clin Cancer Res, 2016, 22(7): 1744-1756.
|
21 |
LI X J, QIAN X, PENG L X, et al. A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation[J]. Nat Cell Biol, 2016, 18: 561-571.
|
22 |
DENG Q, WU M L, DENG J. USP36 promotes tumor growth of non-small cell lung cancer via increasing KHK-A expression by regulating c-MYC-hnRNPH1/H2 axis[J]. Hum Cell, 2022, 35(2): 694-704.
|
23 |
GAUTREY H, JACKSON C, DITTRICH A L, et al. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells[J]. RNA Biol, 2015, 12(10): 1139-1151.
|
24 |
MA Y H, YANG Y, LI J H, et al. NDUFB11 and NDUFS3 regulate arterial atherosclerosis and venous thrombosis: potential markers of atherosclerosis and venous thrombosis[J]. Medicine, 2023, 102(46): e36133.
|
25 |
PANELLI D, LORUSSO F P, PAPA F, et al. The mechanism of alternative splicing of the X-linked NDUFB11 gene of the respiratory chain complex I, impact of rotenone treatment in neuroblastoma cells[J]. Biochim Biophys Acta, 2013, 1829(2): 211-218.
|
26 |
LIANG Z, WEN C, JIANG H, et al. Protein arginine methyltransferase 5 functions via interacting proteins[J]. Front Cell Dev Biol, 2021, 9: 725301.
|
27 |
WEN C, TIAN Z, LI L, et al. SRSF3 and HNRNPH1 regulate radiation-induced alternative splicing of protein arginine methyltransferase 5 in hepatocellular carcinoma[J]. Int J Mol Sci, 2022, 23(23): 14832.
|
28 |
BRIDGES M C, DAULAGALA A C, KOURTIDIS A. LNCcation: lncRNA localization and function[J]. J Cell Biol, 2021, 220(2): e202009045.
|
29 |
ZONG L, HATTORI N, YASUKAWA Y, et al. LINC00162 confers sensitivity to 5-Aza-2'-deoxycytidine via modulation of an RNA splicing protein, HNRNPH1[J]. Oncogene, 2019, 38: 5281-5293.
|
30 |
HILL M, TRAN N. miRNA interplay: mechanisms and consequences in cancer[J]. Dis Model Mech, 2021, 14(4): dmm047662.
|
31 |
VOLK N, SHOMRON N. Versatility of microRNA biogenesis[J]. PLoS One, 2011, 6(5): e19391.
|
32 |
ZHOU Y J, LI G, WANG J, et al. PD-L1: expression regulation[J]. Blood Sci, 2023, 5(2): 77-91.
|
33 |
MINEO M, LYONS S M, ZDIORUK M, et al. Tumor interferon signaling is regulated by a lncRNA INCR1 transcribed from the PD-L1 locus[J]. Mol Cell, 2020, 78(6): 1207-1223.e8.
|
34 |
LUO Z L, XIA M Y, SHI W, et al. Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis[J]. Nature, 2022, 612: 787-794.
|
35 |
TAKAHASHI K, FUJIYA M, KONISHI H, et al. Heterogenous nuclear ribonucleoprotein H1 promotes colorectal cancer progression through the stabilization of mRNA of sphingosine-1-phosphate lyase 1[J]. Int J Mol Sci, 2020, 21(12): E4514.
|
36 |
RAMACHANDRAN B, RAJKUMAR T, GOPISETTY G. Challenges in modeling EWS-FLI1-driven transgenic mouse model for Ewing sarcoma[J]. Am J Transl Res, 2021, 13(11): 12181-12194.
|
37 |
GONG H, XUE B, RU J, et al. Targeted therapy for EWS-FLI1 in ewing sarcoma[J]. Cancers (Basel), 2023, 15(16): 4035.
|
38 |
LI Y F, BAKKE J, FINKELSTEIN D, et al. HNRNPH1 is required for rhabdomyosarcoma cell growth and survival[J]. Oncogenesis, 2018, 7: 9.
|
39 |
OHKI K, KIYOKAWA N, SAITO Y, et al. Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion[J]. Haematologica, 2019, 104(1): 128-137.
|
40 |
WU Y, GUO Q H, JU X Z, et al. HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway[J]. Oncogene, 2021, 40: 4770-4782.
|
41 |
CARRON J, DELLA COLETTA R, LOURENÇO G J. Pseudogene transcripts in head and neck cancer: literature review and in silico analysis[J]. Genes (Basel), 2021, 12(8): 1254.
|
42 |
LU X J, GAO A M, JI L J, et al. Pseudogene in cancer: real functions and promising signature[J]. J Med Genet, 2015, 52(1): 17-24.
|
43 |
QIAN S H, CHEN L, XIONG Y L, et al. Evolution and function of developmentally dynamic pseudogenes in mammals[J]. Genome Biol, 2022, 23(1): 235.
|
44 |
XI S Y, CAI H P, LU J B, et al. The pseudogene PRELID1P6 promotes glioma progression via the hnHNPH1-Akt/mTOR axis[J]. Oncogene, 2021, 40: 4453-4467.
|
45 |
BERTOLDO J B, MÜLLER S, HÜTTELMAIER S. RNA-binding proteins in cancer drug discovery[J]. Drug Discov Today, 2023, 28(6): 103580.
|
46 |
VELAYUTHAM S, SEERATTAN R, SULTAN M, et al. Novel anti-melanoma compounds are efficacious in A375 cell line xenograft melanoma model in nude mice[J]. Biomolecules, 2023, 13(9): 1276.
|